Velankar MM, Nathwani BN, Schlutz MJ, Bain LA, Arber DA, Slovak ML, Weiss LM (1999) Indolent T-lymphoblastic proliferation: report of a case with a 16-year course without cytotoxic therapy. Am J Surg Pathol 23(8):977–981. https://doi.org/10.1097/00000478-199908000-00017

Article  CAS  PubMed  Google Scholar 

Ohgami RS, Arber DA, Zehnder JL, Natkunam Y, Warnke RA (2013) Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma. Adv Anat Pathol 20(3):137–140. https://doi.org/10.1097/PAP.0b013e31828d17ec

Article  CAS  PubMed  Google Scholar 

Eun S, Jeon YK, Jang JJ (2010) Hepatocellular carcinoma with immature T-cell (T-lymphoblastic) proliferation. J Korean Med Sci 25(2):309–312. https://doi.org/10.3346/jkms.2010.25.2.309

Article  PubMed  PubMed Central  Google Scholar 

Ohgami RS, Zhao S, Ohgami JK, Leavitt MO, Zehnder JL, West RB, Arber DA, Natkunam Y, Warnke RA (2012) TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 36(11):1619–1628. https://doi.org/10.1097/PAS.0b013e318264e223

Article  PubMed  Google Scholar 

Pilozzi E, Müller-Hermelink HK, Falini B, de Wolf-Peeters C, Fidler C, Gatter K, Wainscoat J (1999) Gene rearrangements in T-cell lymphoblastic lymphoma. J Pathol 188(3):267–270. https://doi.org/10.1002/(SICI)1096-9896(199907)188:3%3c267::AID-PATH357%3e3.0.CO;2-N

Article  CAS  PubMed  Google Scholar 

Wang ZM, Xiao WB, Zheng SS, Sun K, Wang LJ (2006) Hepatocellular carcinoma with indolent T-lymphoblastic proliferation. Leuk Lymphoma 47(11):2424–2426. https://doi.org/10.1080/10428190600822151

Article  PubMed  Google Scholar 

Kong M, Wang Z, Teng X, Xu L, Liu J, Jiang C, Teng L (2018) Hepatic carcinoma with indolent T-lymphoblastic proliferation (iT-LBP). Int J Clin Exp Pathol 11(3):1674–1678

PubMed  PubMed Central  Google Scholar 

Brar N, Butzmann A, Kumar J, Peerani R, Morgan EA, Grigoriadis G, Kumar B, Tatarczuch RM, Warnke RA, Ohgami RS (2020) LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations. Histopathology 77(6):984–988. https://doi.org/10.1111/his.14176

Article  PubMed  Google Scholar 

Kim WY, Kim H, Jeon YK, Kim CW (2010) Follicular dendritic cell sarcoma with immature T cell proliferation. Hum Pathol 41(1):129–133. https://doi.org/10.1016/j.humpath.2009.05.014

Article  CAS  PubMed  Google Scholar 

Jevremovic D, Roden AC, Ketterling RP, Kurtin PJ, McPhail ED (2016) LMO2 is a specific marker of T-lymphoblastic leukemia/lymphoma. Am J Clin Pathol 145(2):180–190. https://doi.org/10.1093/ajcp/aqv024

Article  CAS  PubMed  Google Scholar 

Sato K, Ohtsuka K, Hasegawa K, Yamagiwa S, Watanabe H, Asakura H, Abo T (1995) Evidence for extrathymic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation. J Exp Med 182(3):759–767. https://doi.org/10.1084/jem.182.3.759

Article  CAS  PubMed  Google Scholar 

Shimizu T, Bannai M, Kawamura H, Yamamoto S, Oya H, Maruyama S, Minagawa M, Kawamura T, Watanabe H, Hatakeyama K, Abo T (2000) Organ specificity of c-kit+ lymphoid precursors in the liver, thymus, and bone marrow. Eur J Haematol 64(6):416–425. https://doi.org/10.1034/j.1600-0609.2000.90158.x

Article  CAS  PubMed  Google Scholar 

Shimizu T, Sugahara S, Oya H, Maruyama S, Minagawa M, Bannai M, Hatakeyama K, Abo T (1999) The majority of lymphocytes in the bone marrow, thymus and extrathymic T cells in the liver are generated in situ from their own preexisting precursors. Microbiol Immunol 43(6):595–608. https://doi.org/10.1111/j.1348-0421.1999.tb02446.x

Article  CAS  PubMed  Google Scholar 

Strauchen JA (2001) Indolent T-lymphoblastic proliferation: report of a case with an 11-year history and association with myasthenia gravis. Am J Surg Pathol 25(3):411–415. https://doi.org/10.1097/00000478-200103000-00018

Article  CAS  PubMed  Google Scholar 

Qian YW, Weissmann D, Goodell L, August D, Strair R (2009) Indolent T-lymphoblastic proliferation in Castleman lymphadenopathy. Leuk Lymphoma 50(2):306–308. https://doi.org/10.1080/10428190802645079

Article  PubMed  Google Scholar 

Yang F, Liu T, Zhao H, Hu Z, Xiao L, Liu Y, Wang X, Li Z (2014) Indolent T-lymphblastic proliferation: report of a case involving the upper aerodigestive tract. Int J Clin Exp Pathol 7(9):6350–6356

PubMed  PubMed Central  Google Scholar 

Quesada AE, Young KH, Medeiros LJ, Thakral B (2018) Indolent T-lymphoblastic proliferation associated with low grade follicular dendritic cell sarcoma and Castleman disease. Pathology 50(3):351–352. https://doi.org/10.1016/j.pathol.2017.09.017

Article  PubMed  Google Scholar 

Chen J, Feng J, Xiao H, Ma Q, Chen Z (2019) Indolent T-lymphoblastic proliferation associated with Castleman disease and low grade follicular dendric cell sarcoma: report of a case and review of literature. Int J Clin Exp Pathol 12(4):1497–1505

PubMed  PubMed Central  Google Scholar 

Yasuda H, Tsutsui M, Ota Y, Tanaka M, Komatsu N (2018) Indolent T-lymphoblastic proliferation concomitant with acinic cell carcinoma mimicking T-lymphoblastic lymphoma: case report and literature review. Histopathology 72(5):862–866. https://doi.org/10.1111/his.13433

Article  PubMed  Google Scholar 

Ohgami RS, Sendamarai AK, Atwater SK, Liedtke M, Fleming MD, Natkunam Y, Warnke RA (2014) Indolent T-lymphoblastic proliferation with disseminated multinodal involvement and partial CD33 expression. Am J Surg Pathol 38(9):1298–1304. https://doi.org/10.1097/PAS.0000000000000197

Article  PubMed  Google Scholar 

Kansal R, Nathwani BN, Yiakoumis X, Moschogiannis M, Sachanas S, Stefanaki K, Pangalis GA (2015) Exuberant cortical thymocyte proliferation mimicking T-lymphoblastic lymphoma within recurrent large inguinal lymph node masses of localized Castleman disease. Hum Pathol 46(7):1057–1061. https://doi.org/10.1016/j.humpath.2015.03.007

Article  PubMed  Google Scholar 

Walters M, Pittelkow MR, Hasserjian RP, Harris NL, Macon WR, Kurtin PJ, Rech KLG (2018) Follicular dendritic cell sarcoma with indolent T-lymphoblastic proliferation is associated with paraneoplastic autoimmune multiorgan syndrome. Am J Surg Pathol 42(12):1647–1652. https://doi.org/10.1097/PAS.0000000000001158

Article  PubMed  Google Scholar 

Chauveau B, Le Loarer F, Bacci J, Baylac F, Dubus P, Ling C, Parrens M (2019) Maladie de Castleman localisée avec prolifération lymphoblastique T indolente [Indolent T-lymphoblastic proliferation in association with localized Castleman disease: a case report]. Ann Pathol 39(1):29–35. https://doi.org/10.1016/j.annpat.2018.09.003

Article  PubMed  Google Scholar 

Moughames E, Kiess AP, Akst LM, Azar A (2019) Sirolimus for the treatment of airway obstruction due to indolent T-lymphoblastic proliferation. Case Reports in Immunology 2019:1724083. https://doi.org/10.1155/2019/1724083

Article  PubMed  PubMed Central  Google Scholar 

Yuanyuan Z, Jianlan X, Yanlin Z, Xiaoge Z (2022) Indolent T-lymphoblastic proliferation: a report of three cases. Virchows Archiv : An Int J Pathol 480(5):1121–1126. https://doi.org/10.1007/s00428-021-03184-5

Article  Google Scholar 

Woo CG, Huh J (2015) TdT+ T-lymphoblastic proliferation in Castleman disease. J Pathol Transl Med 49(1):1–4. https://doi.org/10.4132/jptm.2014.11.17

Article  PubMed  PubMed Central  Google Scholar 

Hartert M, Ströbel P, Dahm M, Nix W, Marx A, Vahl CF (2010) A follicular dendritic cell sarcoma of the mediastinum with immature T cells and association with myasthenia gravis. Am J Surg Pathol 34(5):742–745. https://doi.org/10.1097/PAS.0b013e3181d7a2ee

Article  PubMed  Google Scholar 

Fromm JR, Edlefsen KL, Cherian S, Wood BL, Soma L, Wu D (2020) Flow cytometric features of incidental indolent T lymphoblastic proliferations. Cytometry B Clin Cytom 98(3):282–287. https://doi.org/10.1002/cyto.b.21845

Article  CAS  PubMed  Google Scholar